Nish was discharged in December. His second treatment included a targeted therapy drug called Imatinib, which Cancer Research UK scientists played a part in creating.
“The second treatment I had was Imatinib, and that felt like it was a chisel and a hammer approach, it was far more targeted to the specific area.
I was home but I was shielding heavily and did not really leave my room apart from going to the loo. I ended up still getting COVID, we all did! We had a mix of symptoms but I felt like I actually got off quite lightly in the end but it was such a worrying time and our isolation ended at the start of January.”
Nish is now looking to the future.
“I am on Imatinib now and might have to be on it for the next few years. I am just trying to get back to normal and have got back to my music, I love it. I am a huge football fan, playing and supporting Arsenal too.
I want to raise awareness to show the importance of research and give hope. I was fearing for my life – I was so scared. I had the treatment that I did because of research in the last 10-20 years. I found that research and information from organisations like Cancer Research UK helped me and my family.”